Clinical Trials
4
Active:1
Completed:0
Trial Phases
2 Phases
Phase 1:2
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Phase 2
2 (50.0%)A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Phase 2
Terminated
- Conditions
- Chronic Peripheral Neuropathy Pain in Diabetics
- Interventions
- First Posted Date
- 2008-01-18
- Last Posted Date
- 2009-06-30
- Lead Sponsor
- XTL Biopharmaceuticals
- Target Recruit Count
- 250
- Registration Number
- NCT00597649
- Locations
- 🇺🇸
Four Rivers Clinical Research, Paducah, Kentucky, United States
Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes
- First Posted Date
- 2007-11-04
- Last Posted Date
- 2007-11-04
- Lead Sponsor
- XTL Biopharmaceuticals
- Target Recruit Count
- 336
- Registration Number
- NCT00553592
- Locations
- 🇺🇸
Four Rivers Clinical Research, Paducah, Kentucky, United States
Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection
Phase 1
- Conditions
- Hepatitis C
- First Posted Date
- 2006-03-09
- Last Posted Date
- 2007-03-07
- Lead Sponsor
- XTL Biopharmaceuticals
- Target Recruit Count
- 36
- Registration Number
- NCT00300807
- Locations
- 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
🇺🇸Mt Sinai School of Medicine, New York, New York, United States
🇺🇸University Of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
News
No news found